Neurotech Pharmaceuticals, Inc. (the “Company”) announces the launch of YouTube channel - Uncovering MacTel, a new disease education resource that delivers accessible, patient-centered information for individuals affected by Macular Telangiectasia Type 2 (MacTel).

Uncovering MacTel debuts with 16 short videos featuring the experiences of four individuals living with MacTel. Navigating life with a rare eye disease can be challenging. The series explores key moments in the patient’s journey including the onset of symptoms, the path to diagnosis, navigating uncertainty, and offers advice for others impacted by MacTel.

“Uncovering MacTel was created to help patients better understand their condition through the voices of people who have experienced it firsthand,” said Thomas M. Aaberg, Jr., M.D. “By sharing these authentic stories, we aim to help patients feel more informed, empowered, and less alone in their journey.”

Neurotech is committed to increasing disease awareness and ensuring patients and caregivers have access to reliable, easy-to-understand resources. By leveraging digital platforms like YouTube, patients can be reached where they are actively seeking information.

About Neurotech Pharmaceuticals, Inc.
Neurotech Pharmaceuticals, Inc. is a private biotech company focused on developing and commercializing transformative therapies for chronic eye diseases.

About Macular Telangiectasia Type 2 (MacTel)
Macular Telangiectasia Type 2 (MacTel), is a bilateral, neurodegenerative disease in adults with characteristic localized retinal degeneration that causes the gradual loss of cells in the retina, resulting in vision loss and secondary alterations of the retinal vasculature, the network of blood vessels that supplies oxygen and nutrients to the retina.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260602204911/en/